Versteeg, Anne L.
Gal, Roxanne
Charest-Morin, Raphaele
Verlaan, Jorrit-Jan
Wessels, Hester
Fisher, Charles G.
Verkooijen, Helena M.
Article History
Received: 12 March 2021
Accepted: 2 November 2021
First Online: 23 November 2021
Declarations
:
: Ethics approval was obtained from the REB at the University Medical Center Utrecht, Utrecht, The Netherlands and the University of British Columbia, Vancouver, Canada. All participants provided written informed consent. This study has been conducted according to the guidelines of the Declaration of Helsinki.
: Not applicable.
: The authors have no conflicts of interest to disclose that could have influenced the work reported in this article. Dr. CG Fisher reports consulting fees and royalties from Medtronic, consulting fees from Nuvasive and receives fellowship support paid by Medtronic and AO Spine, not relevant for this article. Dr. JJ Verlaan received an educational grant from DePuy Synthes, and is co-founder of, and holds stocks in SentryX, not relevant for this article. Dr. AL Versteeg received consultancy and travelling support from AO Spine, not relevant for this article.